Knowns and unknowns about congenital hypothyroidism: 2022 update

Area of Science:

• Pediatric Endocrinology
• Neonatal Thyroid Disorders
• Genetics of Endocrine Diseases

Background:

• Existing congenital hypothyroidism (CH) guidelines offer limited detail on specific clinical challenges.
• Several critical aspects of CH management warrant further investigation and expert consensus.

Purpose of the Study:

• To critically examine seven specific clinical issues in congenital hypothyroidism (CH).
• To enhance understanding and guide treatment strategies for pediatric endocrinologists managing CH.
• To stimulate further research and interest in the optimal care of CH patients.

Main Methods:

• A comprehensive review of current literature and expert opinion on selected CH topics.
• Focused discussion on levothyroxine (L-T4) dosing and monitoring in severe CH.
• Analysis of the impact of maternal iodine intake on fetal and neonatal thyroid function.

Main Results:

• Discussion highlights optimal initial levothyroxine (L-T4) dosage and monitoring strategies for severe CH.
• Exploration of the relationship between maternal iodine intake, DUOX2 variants, and serum thyroglobulin levels.
• Evaluation of criteria for genetic diagnosis, distinguishing transient versus permanent CH, and associated cancer risks.

Conclusions:

• Addressing these specific issues can improve the understanding and management of congenital hypothyroidism (CH).
• Further research is needed to refine diagnostic criteria and treatment protocols for CH.
• Optimizing CH care requires a detailed approach to individual patient needs and genetic factors.